EQT AB
EQT
ISIN SE0012853455 / Valor 50056018
EQT AB
UMushroom community rating:
About company
EQT AB is a diversified investment organization with a global footprint, specializing in various sectors including real estate, life sciences, and both private and public equity markets. Through its EQT Exeter division, the company has established itself as a prominent entity in real estate investment management, boasting over $45 billion in total property gross asset value since its inception. This division focuses on delivering value-add, core-plus, and core investment returns for a sophisticated institutional client base that includes pension funds, sovereign wealth funds, and family offices, among others. In the life sciences sector, EQT Life Sciences (formerly known as LSP) positions itself as one of Europe’s leading healthcare investors, with a 30-year history of investing in over 150 private companies and raising more than €3 billion. This branch is dedicated to funding innovative companies in the healthcare and life sciences industries, leveraging a team with deep expertise in medicine, science, and industry. Additionally, EQT Future targets mature market leaders with strong profitability and cash generation, focusing on creating impact within Climate & Nature and Health & Wellbeing sectors. Meanwhile, EQT Public Value adopts a private equity approach to public markets, concentrating on building significant influence positions in Northern European mid-cap publicly-listed companies, aiming to unlock their full potential. Across these diverse platforms, EQT AB employs a strategic approach to investment, combining sector knowledge, analytical skills, and a commitment to driving value and impact.
Summarized from source with an LLMView SourceSector: Business ServicesLatest Results (28.08.2026):
EQT AB — H1 2026 (Jan–Jun 2026): EQT reported resilient first-half 2026 results with adjusted total revenue of €1,407m and adjusted EBITDA of €837m (60% margin). Adjusted net income was €691m and adjusted EPS €0.590. Total AUM reached €291bn and FAUM €155bn at period end. Fundraising, new product launches (notably an AI Infrastructure strategy) and a signed agreement to acquire Coller Capital were the main operational headlines driving growth and strategic expansion.
Key financials
Adjusted Total Revenue €1,407m (IFRS total €1,610m). Adjusted EBITDA €837m (60% margin); IFRS EBITDA €962m. Adjusted Net Income €691m (IFRS Net Income €663m). Adjusted EPS €0.590 (reported/IFRS EPS €0.566).
AUM / FAUM
Total AUM €291bn (end‑period), FAUM €155bn (end‑period). FAUM grew ~10% YTD driven by fundraising and NAV appreciation.
Fundraising and product launches
BPEA IX closed at $15.6bn. EQT Infrastructure VII set a target of €21bn; EQT XI has secured ~50% of target commitments. EQT launched an AI Infrastructure strategy that reached ~$9.4bn FAUM quickly, and the Scaleup Europe Fund (target €5bn) was selected by the European Commission.
Investments and exits
Gross fund investments €19bn in H1 2026 (co-invest capacity ~€9bn for clients). Gross fund exits €7bn (mainly public market sell-downs such as Galderma, Azelis, Enity). EQT returned ~€17bn to fund and co‑investors in H1 and ~€30bn over the last 12 months.
Coller Capital transaction
On 22 Jan 2026 EQT signed to acquire Coller Capital (fee‑generating AUM ~€31bn). Transaction expected to close mid–late Q3 2026 subject to approvals; will create a Secondaries & Solutions reporting segment and broaden EQT’s client offering.
Shareholder distributions and capital return
Total distributions to shareholders €351m in H1 (€269m dividends; €82m share repurchases). AGM approved SEK 5.00 per share in two installments. A further buyback program (up to 4.4m shares) was announced for Jul–Sep 2026 to offset incentive-related dilution.
Balance sheet, liquidity and carried interest
Cash and cash equivalents €843m (30 Jun 2026); net debt €1,596m. Financial investments including carried interest €5,629m. Realized (cash) carried interest in H1 €404m; adjusted carried interest and investment income €266m (reported/IFRS figure €462m reflecting fair‑value changes).
Operational performance and value creation
Key funds delivered positive value creation (Key fund valuations +5% YTD). Infrastructure led with double‑digit uplift driven by digital and energy subsectors; Private Capital showed accelerating portfolio profitability (12–24% EBITDA growth in key vintages over 12 months).
People, governance and strategic positioning
FTE ~1,895 at period end. CEO highlighted continued investments in AI capabilities, private wealth and geographic expansion. Governance updates: Jean‑Eric Salata elected Chair (May 2026); Gustav Segerberg announced as CFO effective 18 July 2026.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
37588 M
Market cap (USD)
1,114,405
Daily traded volume (Shares)
311.7 / 304
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
